Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Chinese Medical Association Publishing House (CMAPH) is the most influential medical academic publisher in China, operating as the publishing arm of the Chinese Medical Association. The organization manages a comprehensive portfolio of over 150 medical journals, including the prestigious 'Chinese' (Zhonghua) series, which covers nearly all clinical and basic medical specialties. CMAPH plays a critical role in the Chinese healthcare ecosystem by establishing clinical guidelines, providing continuing medical education, and facilitating the exchange of medical research both domestically and internationally. Through strategic partnerships with global publishers, it also works to increase the international visibility and impact of Chinese medical research. The publishing house is a key resource for healthcare professionals, researchers, and policy makers across the Greater China region.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Chinese Medical Association Publishing House.